Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Shares Outstanding (Weighted Average) (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Shares Outstanding (Weighted Average) data on record, last reported at $135.1 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 1.04% year-over-year to $135.1 million; the TTM value through Dec 2025 reached $135.1 million, up 1.04%, while the annual FY2025 figure was $135.1 million, 1.04% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $135.1 million in Q4 2025 per AHCO's latest filing, roughly flat from $135.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $135.1 million in Q4 2025 and bottomed at $124.2 million in Q3 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $133.3 million, with a median of $134.2 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 140.64% in 2021, then dropped 1.2% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $126.3 million in 2021, then increased by 6.23% to $134.2 million in 2022, then dropped by 0.01% to $134.2 million in 2023, then fell by 0.3% to $133.8 million in 2024, then grew by 1.04% to $135.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $135.1 million in Q4 2025, $135.0 million in Q3 2025, and $135.0 million in Q2 2025.